Related Experiment Video
Updated: Dec 9, 2025

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review
Wan Yean Chung1, Yan Zhu2, Mohd Hafidz Mahamad Maifiah3
1School of Pharmacy, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia.
Abstract:
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of a wide range of infections. Governments around the world are beginning to devote effort for innovative treatment development to treat these resistant bacteria. Systems biology methods have been applied extensively to provide valuable insights into metabolic processes at system level. Genome-scale metabolic models serve as platforms for constraint-based computational techniques which aid in novel drug discovery. Tools for automated reconstruction of metabolic models have been developed to support system level metabolic analysis. We discuss features of such software platforms for potential users to best fit their purpose of research. In this work, we focus to review the development of genome-scale metabolic models of Gram-negative pathogens and also metabolic network approach for identification of antimicrobial drugs targets.
Related Concept Videos
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...

